Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database.

Tomoyuki YamadaSatoru MitsuboshiKaoru SuzukiMasami NishiharaMasashi Neo

Published in: International journal of clinical pharmacy (2022)

Patients with chronic kidney disease, receiving ceftriaxone at a dosage of > 2 g/day, being treated for over 14 days, and/or females may be at an increased risk of ceftriaxone-induced encephalopathy.

Keyphrases

adverse drug
high glucose
drug induced
diabetic rats
early onset
electronic health record
oxidative stress
endothelial cells
newly diagnosed